Literature DB >> 11702069

Crystal structure of an Xrcc4-DNA ligase IV complex.

B L Sibanda1, S E Critchlow, J Begun, X Y Pei, S P Jackson, T L Blundell, L Pellegrini.   

Abstract

A complex of two proteins, Xrcc4 and DNA ligase IV, plays a fundamental role in DNA non-homologous end joining (NHEJ), a cellular function required for double-strand break repair and V(D)J recombination. Here we report the crystal structure of human Xrcc4 bound to a polypeptide that corresponds to the DNA ligase IV sequence linking its two BRCA1 C-terminal (BRCT) domains. In the complex, a single ligase chain binds asymmetrically to an Xrcc4 dimer. The helical tails of Xrcc4 undergo a substantial conformational change relative to the uncomplexed protein, forming a coiled coil that unwinds upon ligase binding, leading to a flat interaction surface. A buried network of charged hydrogen bonds surrounded by extensive hydrophobic contacts explains the observed tightness of the interaction. The strong conservation of residues at the interface between the two proteins provides evidence that the observed mode of interaction has been maintained in NHEJ throughout evolution.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11702069     DOI: 10.1038/nsb725

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  93 in total

1.  Delineation of the Xrcc4-interacting region in the globular head domain of cernunnos/XLF.

Authors:  Laurent Malivert; Virginie Ropars; Marcela Nunez; Pascal Drevet; Simona Miron; Guilhem Faure; Raphael Guerois; Jean-Paul Mornon; Patrick Revy; Jean-Baptiste Charbonnier; Isabelle Callebaut; Jean-Pierre de Villartay
Journal:  J Biol Chem       Date:  2010-06-17       Impact factor: 5.157

2.  XLF regulates filament architecture of the XRCC4·ligase IV complex.

Authors:  Michal Hammel; Yaping Yu; Shujuan Fang; Susan P Lees-Miller; John A Tainer
Journal:  Structure       Date:  2010-11-10       Impact factor: 5.006

3.  "Similarity trap" in protein-protein interactions could be carcinogenic: simulations of p53 core domain complexed with 53BP1 and BRCA1 BRCT domains.

Authors:  Jin Liu; Yongping Pan; Buyong Ma; Ruth Nussinov
Journal:  Structure       Date:  2006-12       Impact factor: 5.006

4.  Modifying the function of DNA repair nanomachines for therapeutic benefit.

Authors:  William S Dynan; Yoshihiko Takeda; Shuyi Li
Journal:  Nanomedicine       Date:  2006-06       Impact factor: 5.307

5.  End-joining repair of double-strand breaks in Drosophila melanogaster is largely DNA ligase IV independent.

Authors:  Mitch McVey; Dora Radut; Jeff J Sekelsky
Journal:  Genetics       Date:  2004-12       Impact factor: 4.562

Review 6.  Structural biology and bioinformatics in drug design: opportunities and challenges for target identification and lead discovery.

Authors:  Tom L Blundell; Bancinyane L Sibanda; Rinaldo Wander Montalvão; Suzanne Brewerton; Vijayalakshmi Chelliah; Catherine L Worth; Nicholas J Harmer; Owen Davies; David Burke
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-03-29       Impact factor: 6.237

7.  Structural and functional interaction between the human DNA repair proteins DNA ligase IV and XRCC4.

Authors:  Peï-Yu Wu; Philippe Frit; SriLakshmi Meesala; Stéphanie Dauvillier; Mauro Modesti; Sara N Andres; Ying Huang; JoAnn Sekiguchi; Patrick Calsou; Bernard Salles; Murray S Junop
Journal:  Mol Cell Biol       Date:  2009-03-30       Impact factor: 4.272

Review 8.  Non-homologous DNA end joining and alternative pathways to double-strand break repair.

Authors:  Howard H Y Chang; Nicholas R Pannunzio; Noritaka Adachi; Michael R Lieber
Journal:  Nat Rev Mol Cell Biol       Date:  2017-05-17       Impact factor: 94.444

Review 9.  Non-homologous end joining: emerging themes and unanswered questions.

Authors:  Sarvan Kumar Radhakrishnan; Nicholas Jette; Susan P Lees-Miller
Journal:  DNA Repair (Amst)       Date:  2014-02-26

10.  Ovarian cancer and DNA repair: DNA ligase IV as a potential key.

Authors:  Joana Assis; Deolinda Pereira; Rui Medeiros
Journal:  World J Clin Oncol       Date:  2013-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.